These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Huber LC; Distler JH; Moritz F; Hemmatazad H; Hauser T; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Distler O; Jüngel A Arthritis Rheum; 2007 Aug; 56(8):2755-64. PubMed ID: 17665426 [TBL] [Abstract][Full Text] [Related]
14. Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis. Avouac J; Elhai M; Tomcik M; Ruiz B; Friese M; Piedavent M; Colonna M; Bernhardt G; Kahan A; Chiocchia G; Distler JH; Allanore Y Ann Rheum Dis; 2013 Jun; 72(6):1089-98. PubMed ID: 23161903 [TBL] [Abstract][Full Text] [Related]
15. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis. Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342 [TBL] [Abstract][Full Text] [Related]
16. Potential roles of interleukin-17A in the development of skin fibrosis in mice. Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167 [TBL] [Abstract][Full Text] [Related]
17. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235 [TBL] [Abstract][Full Text] [Related]
18. Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis. Desallais L; Avouac J; Fréchet M; Elhai M; Ratsimandresy R; Montes M; Mouhsine H; Do H; Zagury JF; Allanore Y Arthritis Res Ther; 2014 Jul; 16(4):R157. PubMed ID: 25059342 [TBL] [Abstract][Full Text] [Related]
19. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis. Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032 [TBL] [Abstract][Full Text] [Related]
20. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice. Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]